Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol
Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol
TucciPJF. Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol. Arq. Bras. Cardiol. 2020;114(2):304.
Tucci,Paulo J. F.. Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol. Arq. Bras. Cardiol., v. 114, n. 2, p. 304-304, Feb. 2020.
Tucci,P.J.F. (2020). Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol. Arq. Bras. Cardiol.,114(2), 304-304.
Tucci,Paulo J. F.. Short Editorial – Effect of Passive Smoking on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 2, [cited 2025-09-06], pp.304-304. Available from: <https://abccardiol.org/en/short-editorial/short-editorial-effect-of-passive-smoking-on-blood-pressure-response-to-epinephrine-and-felypressin-in-1k1c-hypertensive-rats-treated-or-not-with-atenolol/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
